Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 12 oct 1300 biomolecular condensates their implications neurodegenerative disease.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Professor Andrea Brand

  18. Dr Alison Schuldt

  19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  20. Dr Annalise Katz-Summercorn

    Early detection in oesophageal adenocarcinoma

  21. Miss Aurora Diamante

  22. Mr Adam Peryt

  23. Mr Andrew Lee

  24. Miss Anne Babbage

  25. Ms Adeline Nicholas

  26. Dr Adrian Ionescu

    I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, University of Cambridge, in the Thin Film Magnetism (TFM) group with Prof. Crispin Barnes on an ERC International Training Network project,...

  27. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  28. Dr Fazlur Rahman Talukdar

    I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...

  29. Professor Grant Stewart

    Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...

  30. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

  31. Dr Helen Hatcher

    Dr Hatcher is the Clinical and Regional lead for young people with cancer specialising in sarcomas and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post...

  32. Dr Hanna Najgebauer

    Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.

  33. Mr Justin Davies

    Justin Davies Clinical Director of Digestive Diseases and Consultant Colorectal Surgeon at Addenbrooke's Hospital, and an Associate Lecturer at the University of Cambridge. His thesis was written on molecular stool screening for colorectal cancer, and...

  34. Dr Kate Fife

    Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...

  35. Dr Myriam Ouberai

    I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...

  36. Mr James Watson

  37. Mrs Sarah Fesco

  38. Dr Tony Jackson

    ... method will have wide application to many problems in the biomolecular sciences. ...

  39. Professor Tuomas Knowles

    ... particular interest in developing microfluidic platforms for biomolecular studies. Much of our work has been focused on protein ...

  40. Professor Adrian Liston

    ... within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our ...

  41. Professor Andrew Flewitt

    ... sensors which are capable of edecting mass changes on their surface down to 1 fg in mass. With selective functionalisation of the ...

  42. Dr Andrew Bannister

    ... around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone ...

  43. Professor Anna Philpott

    ... proliferation and differentiation during development, and their application in stem cell and developmental models, will illuminate the ...

  44. Dr Anny Wong

    ... running of the paediatric day unit where children come for their treatment and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...

  45. Professor Anthony Davenport

    ... targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging ... to exist from the human genome but recently paired with their cognate transmitters (urotensin II, apelin, ghrelin, neuromedin U, ...

  46. Dr Arnaud Comment

    ... in vivo imaging, aims at differentiating tissues based upon their metabolic and functional activity rather than structural and anatomic ...

  47. Dr Alex Cagan

    ... processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an ... dynamics in these species could lead to the discovery of their cancer resistance mechanisms, opening the door for novel therapeutic ...

  48. Dr Nitzan Rosenfeld

    ... between tumour changes and ctDNA levels, and their clinical implications. ...

  49. Dr Sumru Bayin

    ... mechanisms that govern neural stem cells not only have implications for facilitating repair but also will allow us to dissect the ...

  50. Professor Simon Mendez-Ferrer

    ... of mesenchymal and haematopoietic stem cells and its implications for bone marrow transplantation procedures and the development of ...

  51. Professor Sir David Klenerman

    ... stages of the oligomerisation of proteins involved in many neurodegenerative diseases. ...

  52. Professor Heike Laman

    ... the recessive mutations in Fbxo7 that give rise to neurodegenerative disease. We use mouse models which have compromised ...

  53. Dr Su Metcalfe

    ... target endogenous neural stem cells in vivo for treatment of neurodegenerative diseases. 2: Application of targeted nanotherapy to control ...

  54. Dr Ahsan MEMON

    ... for driving cell shape changes in physiological and disease conditions. Additionally, Ahsan has designed a device capable of ...

  55. Dr Andrew Murray

    Our interest lies in the control of mitochondrial respiration and energy metabolism. We are interested in the metabolic response to dietary manipulation and alterations in oxygen supply, including the matching of oxygen demand and supply. We study this...

  56. Dr Alasdair Russell

    ... range of pre-clinical trials to advance our understanding of disease. ...

  57. Mr Amit Roshan

    ... in early melanoma, and progressing our understanding of disease mechanisms in the initiation and progression of localised melanoma. ...

  58. Dr Anna Piskorz

    ... helping in better patient stratification, earlier disease diagnosis, monitoring patient response and improving patient management ...

  59. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  60. Professor Clemens Kaminski

    ... study of protein-protein interactions, which are linked to disease, in particular to cancer, Parkinson's disease and Malaria. The techniques are also used for research into molecular ...

Pages